LAVA Therapeutics Announces Participation at Upcoming Scientific Conferences
02 nov. 2021 07h00 HE
|
Lava Therapeutics N.V.
UTRECHT, The Netherlands and PHILADELPHIA, Nov. 02, 2021 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. (Nasdaq: LVTX), a clinical-stage biotechnology company focused on developing its proprietary...
FLORIDA CANCER SPECIALISTS & RESEARCH INSTITUTE BREAST CANCER PARTNERSHIP RECEIVES NATIONAL ACCREDITATION
21 oct. 2021 15h23 HE
|
Florida Cancer Specialists & Research Institute
Davenport, Fla., Oct. 21, 2021 (GLOBE NEWSWIRE) -- Florida Cancer Specialists & Research Institute (FCS), in collaboration with AdventHealth Heart of Florida and Central Florida Cancer...
LAVA Therapeutics Receives FDA Orphan Drug Designation for LAVA-051 for the Treatment of Chronic Lymphocytic Leukemia
15 oct. 2021 07h00 HE
|
Lava Therapeutics N.V.
UTRECHT, The Netherlands and PHILADELPHIA, Oct. 15, 2021 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. (Nasdaq: LVTX), a clinical-stage biotechnology company, today announced that the U.S. Food and...
CORRECTING and REPLACING: LAVA Therapeutics to Present its Bispecific Gamma Delta T Cell Engagers for Treatment of Cancer at the 2021 AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics
07 oct. 2021 12h36 HE
|
Lava Therapeutics N.V.
UTRECHT, The Netherlands and PHILADELPHIA, Oct. 07, 2021 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by LAVA Therapeutics N.V. (Nasdaq: LVTX), please note that in...
LAVA Therapeutics to Present its Bispecific Gamma Delta T Cell Engagers for Treatment of Cancer at the 2021 AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics
07 oct. 2021 11h31 HE
|
Lava Therapeutics N.V.
UTRECHT, The Netherlands and PHILADELPHIA, Oct. 07, 2021 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. (Nasdaq: LVTX), a clinical-stage biotechnology company focused on developing bispecific gamma...
Florida Cancer Specialists & Research Institute Expands Next Generation Genomic Testing Capabilities to Advance Cancer Care
07 oct. 2021 10h10 HE
|
Florida Cancer Specialists & Research Institute
Fort Myers, Fla, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Florida Cancer Specialists & Research Institute (FCS) recently expanded its molecular testing capabilities at its state-of-the-art Pathology...
Florida Cancer Specialists & Research Institute Names Michael Diaz, MD as President & Managing Physician
01 oct. 2021 13h03 HE
|
Florida Cancer Specialists & Research Institute
Fort Myers, Fla, Oct. 01, 2021 (GLOBE NEWSWIRE) -- Florida Cancer Specialists & Research Institute (FCS) is pleased to announce that Michael Diaz, MD will assume the role of President &...
Kinnate Biopharma Inc. Presents Preclinical Data on its Lead FGFR Inhibitor Candidate at the JCA-AACR Precision Cancer Medicine International Conference
13 sept. 2021 08h00 HE
|
Kinnate Biopharma
SAN FRANCISCO and SAN DIEGO, Sept. 13, 2021 (GLOBE NEWSWIRE) -- Kinnate Biopharma Inc. (Nasdaq: KNTE) (“Kinnate”), a biopharmaceutical company focused on the discovery and development of small...
Florida Cancer Specialists & Research Institute’s Integrated Value-Based Care Model
25 août 2021 16h06 HE
|
Florida Cancer Specialists & Research Institute
Fort Myers, Fla, Aug. 25, 2021 (GLOBE NEWSWIRE) -- Since 2016, Florida Cancer Specialists & Research Institute (FCS) has been a national leader in the transition of oncology care from a...
HCW Biologics Showcases Scientific Paper in Molecular Therapy Highlighting Potential of HCW9218 as Novel, Bifunctional Cancer Immunotherapeutic
24 août 2021 07h32 HE
|
HCW Biologics, Inc
Lead Drug Candidate Engineered Using Tissue FactOr-Based FusIon (TOBI™) Platform Preclinical Data Demonstrated HCW9218 Antitumor Activity as Single-Agent Monotherapy and as an Adjunct to Enhance...